
ENA 2020: Existing heart drugs may help cancer patients respond better to PD(L)1 immunotherapy
Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses…
Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses…